Literature DB >> 23798581

Clinical and epidemiologic profile of cutaneous leishmaniasis in Colombian children: considerations for local treatment.

Victor M Blanco1, Alexandra Cossio, Javier D Martinez, Nancy Gore Saravia.   

Abstract

Treatment alternatives have seldom been evaluated in children with cutaneous leishmaniasis (CL). We examine the clinical/epidemiological profile of children with CL considering international guidelines for local treatment. Descriptive analyses were conducted using International Center for Medical Research and Training (CIDEIM) case reports of parasitologically diagnosed patients ≤ 14 years of age from 2004 to 2010. Eligibility for local treatment based on World Health Organization/Pan American Health Organization (WHO/PAHO) criteria was determined. Among 380 children, 90% presented lesions of < 3 months duration, 54% presented single lesions < 30 mm in diameter, and 45% were ≤ 5 years old. Lesions on the head and neck were more frequent among children 0-5 years, and lesions below the head/neck were more frequent among 11- to 14-year-old children (P = 0.004). Using PAHO and WHO criteria, 26% and 53% of children, respectively, were eligible for local treatment. Recommended local treatments for New World CL have potential but limited applicability in children. Individual risk-benefit assessment and effectiveness data in children may increase eligibility.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23798581      PMCID: PMC3741260          DOI: 10.4269/ajtmh.12-0784

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

1.  Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy.

Authors:  Iza M F Lobo; Milena B P Soares; Tania M Correia; Luiz A R de Freitas; Maria Ines Oliveira; Maria Nakatani; Eduardo Netto; Roberto Badaro; John R David
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-11-04       Impact factor: 2.184

2.  Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.

Authors:  R Reithinger; M Mohsen; M Wahid; M Bismullah; R J Quinnell; C R Davies; J Kolaczinski; J R David
Journal:  Clin Infect Dis       Date:  2005-03-16       Impact factor: 9.079

3.  [Clinical findings of tegumentary leishmaniasis in children under five years of age in an endemic area of Leishmania (Viannia) braziliensis].

Authors:  Julia Ampuero; Vanize Macêdo; Philip Marsden
Journal:  Rev Soc Bras Med Trop       Date:  2006-02-23       Impact factor: 1.581

4.  Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis.

Authors:  Patricia de Oliveira Camera; Juliana Junger; Felipe do Espírito Santo Silva Pires; Marise Mattos; Manoel Paes Oliveira-Neto; Octavio Fernandes; Claude Pirmez
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-06-12       Impact factor: 2.184

5.  Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.

Authors:  Adriana Cruz; Petrie M Rainey; Barbara L Herwaldt; Grazia Stagni; Ricardo Palacios; Rodolfo Trujillo; Nancy G Saravia
Journal:  J Infect Dis       Date:  2007-01-11       Impact factor: 5.226

6.  Evidence for leishmania (viannia) parasites in the skin and blood of patients before and after treatment.

Authors:  Carolina Vergel; Ricardo Palacios; Horacio Cadena; Claudia Jimena Posso; Liliana Valderrama; Mauricio Perez; John Walker; Bruno Luis Travi; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2006-07-10       Impact factor: 5.226

7.  Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients.

Authors:  A Schubach; F Haddad; M P Oliveira-Neto; W Degrave; C Pirmez; G Grimaldi; O Fernandes
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

8.  [Comparative study of American tegumentary leishmaniasis between childhood and teenagers from the endemic areas Buriticupu, Maranhao and Corte de Pedra, Bahia, Brazil].

Authors:  J M Costa; I T Balby; E J Rocha; A R da Silva; J M Rebêlo; L A Ferreira; M E Gama; M dos R Branco; M N Burattini; N de J Soares
Journal:  Rev Soc Bras Med Trop       Date:  1998 May-Jun       Impact factor: 1.581

Review 9.  Interventions for American cutaneous and mucocutaneous leishmaniasis.

Authors:  Urbà González; Mariona Pinart; Mónica Rengifo-Pardo; Antonio Macaya; Jorge Alvar; John A Tweed
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

10.  Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods.

Authors:  K A Weigle; M de Dávalos; P Heredia; R Molineros; N G Saravia; A D'Alessandro
Journal:  Am J Trop Med Hyg       Date:  1987-05       Impact factor: 2.345

View more
  9 in total

1.  Eligibility for Local Therapies in Adolescents and Adults with Cutaneous Leishmaniasis from Southwestern Colombia: A Cross-Sectional Study.

Authors:  Andrés Felipe Uribe-Restrepo; Miguel Dario Prieto; Alexandra Cossio; Mayur M Desai; María Del Mar Castro
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

2.  Epidemiology of Cutaneous Leishmaniasis in a Colombian Municipality.

Authors:  Diego Alejandro Medina-Morales; Manuel E Machado-Duque; Jorge Enrique Machado-Alba
Journal:  Am J Trop Med Hyg       Date:  2017-08-18       Impact factor: 2.345

3.  Head and neck cutaneous leishmania: clinical characteristics, microscopic features and molecular analysis in a cohort of 168 cases.

Authors:  Gabriel Dunya; Robert Habib; Roger V Moukarbel; Ibrahim Khalifeh
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-15       Impact factor: 2.503

4.  Sensitivity and Specificity of the Remote Evaluation of Therapeutic Response in Cutaneous Leishmaniasis Using Photographs from a Mobile Application.

Authors:  Alejandra Maria Del Castillo; Maria Del Mar Castro; Alexandra Cossio; Jonny Alejandro García Luna; Domiciano Rincón; Ruth Mabel Castillo; Miguel Darío Prieto; David Esteban Rebellón-Sánchez; Andrés Navarro; Neal Alexander
Journal:  Am J Trop Med Hyg       Date:  2022-07-25       Impact factor: 3.707

5.  Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.

Authors:  Caspar J Hodiamont; Piet A Kager; Aldert Bart; Henry J C de Vries; Pieter P A M van Thiel; Tjalling Leenstra; Peter J de Vries; Michèle van Vugt; Martin P Grobusch; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

6.  Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.

Authors:  Brandon A Berger; Alexandra Cossio; Nancy Gore Saravia; Maria Del Mar Castro; Sergio Prada; Allison H Bartlett; Mai T Pho
Journal:  PLoS Negl Trop Dis       Date:  2017-04-06

7.  Interventions to treat cutaneous leishmaniasis in children: A systematic review.

Authors:  Andrés Uribe-Restrepo; Alexandra Cossio; Mayur M Desai; Diana Dávalos; María Del Mar Castro
Journal:  PLoS Negl Trop Dis       Date:  2018-12-14

8.  Burden and risk factors of cutaneous leishmaniasis in a peri-urban settlement in Kenya, 2016.

Authors:  Isaac Ngere; Waqo Gufu Boru; Abdikadir Isack; Joshua Muiruri; Mark Obonyo; Sultani Matendechero; Zeinab Gura
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

9.  Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.

Authors:  María Del Mar Castro; Maria Adelaida Gomez; Anke E Kip; Alexandra Cossio; Eduardo Ortiz; Adriana Navas; Thomas P C Dorlo; Nancy Gore Saravia
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.